Skip to Main Content

FDA Approves New Guardant360® Liquid CDx for Comprehensive Genomic Profiling. Read More

Guardant Health Receives Medicare Coverage for Guardant360 Response™ to Monitor Cancer Patient Response to Immunotherapy